PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.25
Similar ESG score to ANVS's 62.21. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
56.30
Environmental score 1.1-1.2x ANVS's 47.17. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
59.71
Social score 90-95% of ANVS's 64.21. Bill Ackman would demand clear social improvement catalysts.
61.73
Governance score 80-90% of ANVS's 75.24. Walter Schloss would scrutinize management accountability and board independence.